Last updated on March 2019

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma


Brief description of study

A study designed to evaluate the safety and efficacy of venetoclax plus dexamethasone (VenDex) compared with pomalidomide plus dexamethasone (PomDex) in participants with t(11;14)-positive Relapsed or Refractory Multiple Myeloma.

Subjects randomized to Arm 2 (PomDex) may elect, if eligible, to receive VenDex therapy after documented disease progression per International Myeloma Working Group (IMWG) criteria.

Clinical Study Identifier: NCT03539744

Contact Investigators or Research Sites near you

Start Over

Mayo Clinic /ID# 200075

Jacksonville, FL United States

Norton Cancer Institute /ID# 200834

Louisville, KY United States

Karmanos Cancer Institute /ID# 201377

Detroit, MI United States

Henry Ford Hospital /ID# 171531

Detroit, MI United States

Mayo Clinic - /ID# 201091

Rochester, MN United States

Cleveland Clinic Foundation /ID# 202247

Cleveland, OH United States

UPMC Hillman Cancer Ctr /ID# 200063

Pittsburgh, PA United States

Gibbs Cancer Center & Research /ID# 200935

Spartanburg, SC United States

MD Anderson Cancer Center /ID# 200060

Houston, TX United States

Liverpool Hospital /ID# 202431

Liverpool, Australia

Wollongong Hospital /ID# 205545

Wollongong, Australia

ICON Cancer Foundation /ID# 205663

South Brisbane, Australia

CHU Nancy - Brabois /ID# 201076

Vandoeuvre-Lès-Nancy, France

Centre Hospitalier Lyon Sud /ID# 200097

Pierre Benite CEDEX, France

Hadassah /ID# 169474

Jerusalem, Israel

L'Istituto di Ricovero e Cura /ID# 170955

Rionero IN Volture, Italy

Samsung Medical Center /ID# 202710

Seoul, Korea, Republic of

Moscow State budget healthcare /ID# 169685

Moskva, Russian Federation

City Clinical Hospital 52 /ID# 206289

Moscow, Russian Federation

LLC Novaya Clinica /ID# 169689

Pyatigorsk, Russian Federation

Almazov North-West Federal Med /ID# 169681

Sankt-peterburg, Russian Federation

Leningrad Regional Clin Hosp /ID# 202776

St. Petersburg, Russian Federation

Raffles Hospital /ID# 204408

Singapore, Singapore

Tan Tock Seng Hospital /ID# 204374

Singapore, Singapore

Uddevalla sjukhus /ID# 201315

Uddevalla, Sweden

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.